Back to BARCLAYS PLC BARCLAYS PLC

CRVSCRVS
31 quarters

Position history for BARCLAYS PLCBARCLAYS PLC's holdings in CORVUS PHARMACEUTICALS INC

BARCLAYS PLC holds 315,749 shares of CRVS (CORVUS PHARMACEUTICALS INC), worth $4.7M as of 2026-Q2. The position was increased (+29.5% shares). CRVS represents 0.0% of BARCLAYS PLC's portfolio.

Current Value

$4.7M

Current Shares

315,749

Total Value Change

+$4.7M

Total Shares Change

+315,606

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
315,749
+29.5%
$4.7M0.0%$14.94
34
2026-Q1
Decreased
243,776
-38.3%
$3.6M0.0%$17.53
0
2025-Q4
Increased
394,766
+27.7%
$3M0.0%$7.49
33
2025-Q3
Decreased
309,152
-10.0%
$2.3M0.0%$7.28
0
2025-Q2
Increased
343,526
+312.7%
$1.4M0.0%$3.89
41
2025-Q1
Decreased
83,231
-21.5%
$264,6750.0%$3.38
0
2024-Q4
Increased
106,019
+106.0Kx
$567,2010.0%$5.25
39
2024-Q3
Unchanged
1
0.0%
$50.0%$5.15
0
2024-Q2
Unchanged
1
0.0%
$20.0%$1.82
0
2024-Q1
Unchanged
1
0.0%
$20.0%$1.78
0
2023-Q4
Decreased
1
-100.0%
$20.0%$1.76
0
2023-Q3
Increased
13,682
+13.7Kx
$19,9750.0%$1.46
21
2023-Q2
Unchanged
1
0.0%
$20.0%$2.23
0
2023-Q1
Unchanged
1
0.0%
$10.0%$0.79
0
2022-Q4
Unchanged
1
0.0%
$10.0%$0.85
0
2022-Q3
Decreased
1
-100.0%
$00.0%$0.78
0
2022-Q2
Decreased
9,671
-12.8%
$10,0000.0%$1.02
0
2022-Q1
Decreased
11,096
-52.1%
$18,0000.0%$1.57
0
2021-Q4
Increased
23,186
+23.2Kx
$56,0000.0%$2.46
23
2021-Q3
Decreased
1
-75.0%
$00.0%$6.32
0
2021-Q2
Decreased
4
-99.3%
$00.0%$2.71
0
2021-Q1
Increased
537
+133x
$2,0000.0%$2.94
12
2020-Q4
Unchanged
4
0.0%
$00.0%$3.77
0
2020-Q3
Decreased
4
-99.8%
$00.0%$3.93
0
2020-Q2
Increased
2,209
+200x
$6,0000.0%$2.87
17
2020-Q1
Decreased
11
-52.2%
$00.0%$2.22
0
2019-Q4
Decreased
23
-69.7%
$00.0%$4.89
0
2019-Q3
Decreased
76
-99.4%
$00.0%$3.15
0
2019-Q2
Increased
13,632
+241.2%
$51,0000.0%$3.74
23
2019-Q1
Increased
3,995
+2693.7%
$16,0000.0%$4.02
20
2018-Q4
New
143
-
$00.0%$3.61
17

Other major holders of CRVS: BlackRock, Inc., STATE STREET CORP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used